Bioreduction in the Activation of Drugs

ISSN： 1362-3095

Source： International Journal of Radiation Biology, Vol.51, Iss.4, 1987-04, pp. : 761-761

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peptides and Small Molecules Targeting the Plasminogen Activation System: Towards Prophylactic Anti-Metastasis Drugs for Breast Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite

Immunomodulatory Drugs

By Crane Edward List Alan

Cancer Investigation, Vol. 23, Iss. 7, 2005-10 ,pp. : 625-634

Informa Healthcare

Access to resources Recommend Favorite

The EMEA: Is It Delivering Drugs To Europe?

By Sauer F.

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1095-1096

Elsevier

Access to resources Recommend Favorite

New Chemo and Radiosensitising Drugs

By Singh B.B.

International Journal of Radiation Biology, Vol. 50, Iss. 2, 1986-08 ,pp. : 371-372

Informa Healthcare

Access to resources Recommend Favorite

Thalidomide Analogues as Anticancer Drugs

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 167-174

Bentham Science Publishers

Access to resources Recommend Favorite